Issues in the use of inhaled glucocorticoids

被引:159
作者
Kamada, AK [1 ]
Szefler, SJ [1 ]
Martin, RJ [1 ]
Boushey, HA [1 ]
Chinchilli, VM [1 ]
Drazen, JM [1 ]
Fish, JE [1 ]
Israel, E [1 ]
Lazarus, SC [1 ]
Lemanske, RF [1 ]
Cherniak, RM [1 ]
Hurd, SS [1 ]
Peters, SP [1 ]
Sorkness, C [1 ]
Szefler, SJ [1 ]
Zwillich, CW [1 ]
机构
[1] NATL JEWISH CTR IMMUNOL & RESP MED, DEPT MED, DENVER, CO 80206 USA
关键词
D O I
10.1164/ajrccm.153.6.8665030
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Asthma is now regarded as an inflammatory disease, and inhaled glucocorticoids (iGCs) are recommended earlier in the course of treatment of patients with this disorder. Although iGCs are highly efficacious in treating asthma, many questions about this treatment modality remain unanswered. The purpose of this review is to define those areas where data are controversial or limited and where further research is needed regarding this important mode of treatment.
引用
收藏
页码:1739 / 1748
页数:10
相关论文
共 85 条